Postmenopausal Articles

Postmenopausal Articles:

Calcium and Heart Health – Flawed Study Alarms Women

A recent study published in the British Medical Journal has insinuated that calcium intake in elderly women may increase the risk for a heart attack. The study involved 1471 postmenopausal women (mean age 74). The story has been spread by major news media and has confused and needlessly worried many women who are taking calcium for their bone health. The study contains numerous flaws and therefore its conclusion is not reliable.

Read More: Bone and Joint Helper™, bone loss, Calcium, Calcium AEP, citric acid, Coral Calcium, Daily Bone Xcel™, Daily Energy Multiple Vitamin™, Daily Super Pack™, DHA, elderly women, flawed study, magnesium, postmenopausal, Tri-Cal, Vitamin D

Low Melatonin Associated with Breast Cancer

Researchers just demonstrated that low melatonin levels are a new risk factor for invasive breast cancer in postmenopausal women. They had already demonstrated the same finding in premenopausal women.

Read More: breast cancer, Melatonin, postmenopausal

Bone Loss Linked to Hardening Arteries

Postmenopausal women have another good reason to do everything they can to help maintain healthy bone density – the failure to do so is now linked to an increase in plaque in the carotid artery

Read More: atherosclerosis, bone loss, carotid artery, postmenopausal

Postmenopausal Weight Gain Increases Breast Cancer Risk

A new study of 5,450 postmenopausal women shows double the risk for breast cancer in women with elevated insulin. As I recently reported, this risk goes up further if a postmenopausal woman is also taking estradiol, whether from horse urine or bioidentical.

Read More: breast cancer, insulin resistance, postmenopausal

Overweight Postmenopausal Women are Low in Vitamin D

Vitamin D is emerging as an important metabolic nutrient, having a definite role in the health of stored fat – although that role has not yet been clearly defined. Nevertheless, a new study using x-ray absorptiometry measurements of total body and regional fat mass in overweight postmenopausal women without osteoporosis found that fat mass significantly increased as vitamin D levels declined.

Read More: overweight, postmenopausal, Triglycerides, Vitamin D

Magnesium – The Anti-Inflammatory Mineral

A new study of 3,713 postmenopausal women shows that magnesium is a powerful anti-inflammatory nutrient. Each 100 mg of magnesium per day was associated with a significant reduction in various inflammatory markers.

Read More: anti-inflammatory, CRP, IL6, magnesium, postmenopausal, TNFa

Antidepressants Linked to a 67% Increased Risk of Death

Researchers followed 136,000 postmenopausal women taking part in the Women’s Health Initiative and found that those who started taking antidepressants during the study had a 67% increased risk of death from any cause during the 6 year follow-up period of the study. They also had double the risk for a hemorrhagic stroke or a fatal stroke.

Read More: all cause mortality, Anti-depressants, Daily Energy Multiple Vitamin™, PhosphatidylSerine PS, postmenopausal, Super B Complex

Calcium Hydroxyapatite is an Effective Bone Builder

Your body produces calcium hydroxyapatite, which is a three-dimensional calcium-rich structure that is the building block of bone. Dietary supplements of calcium hydroxyapatite are a true bone food and have been shown to be a superior form of calcium for bone health.

Read More: bone building, bone density, Calcium Hydroxyapatite, osteoporosis, postmenopausal

Avandia and Actos Increase Fracture Risk

The often-prescribed diabetic medications Avandia and Actos have now been proven to cause an increase risk in fractures in postmenopausal women. In men if these drugs are combined with a potassium-robbing diuretic, then the fracture risk is also increased. The FDA is currently considering whether to remove Avandia from the market because it causes heart attacks. Actos is eqally as risky as Avandia in regard to fracture, but it has not proven as dangerous as Avandia with heart attack concerns. This is the third time these researchers have published conclusive data on this risk — and the FDA twiddles its thumbs.

Read More: Actos, Avandia, Bone fracture risk, FDA, metabolism, postmenopausal